Enhancing Imaging Capabilities with Breast Tomosynthesis

Siemens HealthcareSiemens Healthcare has now integrated 3D tomosynthesis into its Mammomat Inspiration digital mammography platform. This technology compiles three-dimensional images of the breast and can therefore detect tumors even if hidden by overlapping tissue. This enables a more accurate diagnosis than before and reduces the number of false positive findings. The first Mammomat systems with tomosynthesis have now been installed in Germany and in Belgium.

Dr. Renate Tewaag from Radprax - a group of practices specializing in radiology, nuclear medicine and radiation therapy - was the first radiologist in Germany to use this new Siemens technology. "With tomosynthesis we are witnessing a fascinating further development in digital mammography. This 3D technology offers impressive improvements in the detection of detail, which benefit both patients and radiologists alike: We can be more certain in our diagnosis, while women being examined can feel more reassured", explained Dr. Tewaag. "Tomosynthesis makes mammography less stressful for both the physician and patient. Based on current first impressions, additional examinations and interventions can be avoided with a clear conscience. Lesions hidden within the dense glandular tissue are identified at an earlier stage."

So far, conventional analog mammography and digital full-field mammography was only able to display the three-dimensional anatomical structure of the breast on a two-dimensional level. This made diagnosis more difficult and limited the possibility of the physician identifying certain types of tumor; since, anatomical structures could overlap and obscure lesions. The 3D tomosynthesis technology in the Mammomat Inspiration overcomes these limitations: The technology acquires several projections of the breast from different angles using a fast detector based on amorphous Selenium (aSe) and uses this raw data to generate a 3D volume set. This enables a better analysis of the type and size of lesions as well as microcalcifications compared to conventional methods.

Tomosynthesis increases the sensitivity and specificity of mammography, as well as improving tumor differentiation and classification.

Tomosynthesis differs from conventional mammography in the same way that, for example, a CT scan (computer tomography) differs from a classical X-ray image. During the examination, the Xray tube moves in a 50-degree arc around the breast, taking 25 low-dose images. The images are then used as raw data to construct high-resolution 3D images. High spatial resolution and a wide acquisition angle result in the production of mammography images with unparalleled image quality.

The digital Mammomat Inspiration system with basic screening and diagnostic functions has been on the market since the end of 2007 and is widely used in hospitals and medical practices around the world. Mammomat Inspiration offers screening, diagnostics, stereotactic biopsy, and now tomosynthesis for the first time together on a single integrated digital platform. Any hospital or practice can purchase a screening device and add the biopsy and 3D tomosynthesis applications at a later time if necessary. Soon, all installed systems of this type can be upgraded on-site with the tomosynthesis function.

Related news articles:

About The Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens is the only company to offer customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 49,000 employees worldwide and operates in over 130 countries. In fiscal year 2008 (to September 30), the Sector posted revenue of 11.2 billion euros and profit of 1.2 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...